

(ShareCast News) - UBS downgraded Shire to 'neutral' from 'buy' and cut the price target to 5,000p from 5,600p saying a tougher environment for expens...


** UBS analysts say investors in healthcare stocks should seek exposure to oncology and new expensive drugs which displace older expensive drugs; avoi...


(ShareCast News) - Pharmaceuticals' recent underperformance versus Mining stocks might be set to end, strategists at Deutsche Bank said. The approxima...


* Need for premium could lift price to $26 bln, analysts say * J&J has had preliminary talks with Swiss biotech firm * Actelion could also appeal to d...


(ShareCast News) - Irish pharmaceutical company Shire announced that it will expand its operations in Cambridge, Massachusetts through the establishme...